WBW M Botes

W M Botes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


W M Botes has a total of 1 co-authors. Here are the top co-authors by number of shared publications:

  • D W Thaldar

    Health Law and Bioethics, School of Law, University of KwaZulu-Natal, Durban, South Africa

    1 shared publication

Latest Publications

  • Open Access

    Informed consent during pandemics: Experimental medicine, experienced consent

    by M Botes

    No known cure exists for COVID-19, and medical practitioners are exhausted and at their wits' end trying to find treatments that prevent patients from ending up in hospital or intensive care, or even dying. A variety of treatments tried by medical practitioners include standard registered medicine, investigational or so-called experimental, unapproved or preapproved medicines, emergency or compassionate-use authorised medicine and pre-market approved medicine. However, the medicines that can be accessed via each of these categories are at different stages of efficacy testing and knowledge about adverse effects, dosages and risks. To obtain ethical and legal informed consent, medical practitioners must deal with a lot of medical uncertainty, and care must be taken to ensure that the patient understands the difference in risks they may be willing to take depending on the medicine's stage of development. Often additional information is required to obtain ethical consent as opposed to legal consent. A purely legal approach to informed consent, especially when dealing with the medical uncertainties of health emergencies and pandemics, may lead to patients' consent lacking in enough substance to be truly considered legal and ethical. Informed consent as respect for autonomy in this sense requires more than the patient's explicit agreement or compliance with a certain treatment proposal. This article explains the difference in consent content attached to each different stage of a medicine's development, especially considering the additional difficulties posed by obtaining truly informed consent during a pandemic with uncertain characteristics, treatment and solutions.

  • Open Access

    COVID-19 and quarantine orders: A practical approach

    by W M Botes, D W Thaldar

    COVID-19 and quarantine orders: A practical approach